These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 27989491)

  • 21. Plasma proinsulin in first-degree relatives of type 2 diabetic subjects.
    Beer SF; O'Rahilly S; Spivey RS; Hales CN; Turner RC
    Diabetes Res; 1990 Jun; 14(2):51-4. PubMed ID: 2134213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High fasting serum insulin level due to autoantibody interference in insulin immunoassay discloses autoimmune insulin syndrome: a case report.
    Lamy PJ; Sault C; Renard E
    Ann Biol Clin (Paris); 2016 Aug; 74(4):490-4. PubMed ID: 27492703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin and C-peptide responses to 75 g oral glucose load in the healthy man.
    Bonora E; Zavaroni I; Alpi O; Pezzarossa A; Bruschi F; Guerra L; Dall'Aglio E; Coscelli C; Butturini U
    Diabete Metab; 1986 Jun; 12(3):143-8. PubMed ID: 3525269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generating a reference interval for fasting serum insulin in healthy nondiabetic adult Chinese men.
    Li S; Huang S; Mo ZN; Gao Y; Yang XB; Chen XJ; Zhao JM; Qin X
    Singapore Med J; 2012 Dec; 53(12):821-5. PubMed ID: 23268156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reference values for fasting insulin in 75 year old females and males.
    Larsson A; Stridsberg M; Lind L
    Clin Biochem; 2013 Aug; 46(12):1125-1127. PubMed ID: 23578739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analytical evaluation and clinical application of insulin and C-peptide by a whole blood, lateral flow, point of care (POC) assay system.
    Jekarl DW; Choi H; Kim ES; Lee S; Park HI; Kim M; Kim Y
    Scand J Clin Lab Invest; 2019 Sep; 79(5):347-353. PubMed ID: 31210062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Confusion in the interpretation of prolactin levels caused by inappropriately low reference intervals.
    Sabogal Pineros YS; Deckers MML; de Bie P; Heijboer AC; Hillebrand JJ
    Endocr Connect; 2024 Oct; ():. PubMed ID: 39422626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparability of C-Peptide Measurements - Current Status and Clinical Relevance.
    Hörber S; Orth M; Fritsche A; Peter A
    Exp Clin Endocrinol Diabetes; 2023 Mar; 131(3):173-178. PubMed ID: 36630986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Harmonization of immunoassays for biomarkers in diabetes mellitus.
    Hörber S; Achenbach P; Schleicher E; Peter A
    Biotechnol Adv; 2020; 39():107359. PubMed ID: 30802485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IMMULITE 2000 age and sex-specific reference intervals for alpha fetoprotein, homocysteine, insulin, insulin-like growth factor-1, insulin-like growth factor binding protein-3, C-peptide, immunoglobulin E and intact parathyroid hormone.
    Soldin OP; Dahlin JR; Gresham EG; King J; Soldin SJ
    Clin Biochem; 2008 Aug; 41(12):937-42. PubMed ID: 18503765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Standardization of C-peptide measurements.
    Little RR; Rohlfing CL; Tennill AL; Madsen RW; Polonsky KS; Myers GL; Greenbaum CJ; Palmer JP; Rogatsky E; Stein DT
    Clin Chem; 2008 Jun; 54(6):1023-6. PubMed ID: 18420730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. WHO international reference reagents for human proinsulin and human insulin C-peptide.
    Bristow AF; Das RE
    J Biol Stand; 1988 Jul; 16(3):179-86. PubMed ID: 3170616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of 11 human insulin assays: implications for clinical investigation and research.
    Manley SE; Stratton IM; Clark PM; Luzio SD
    Clin Chem; 2007 May; 53(5):922-32. PubMed ID: 17363420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How the immunoassay transformed C-peptide from a duckling into a swan.
    Roth J; Whitford I; Dankner R; Szulc AL
    Diabetologia; 2012 Apr; 55(4):865-9. PubMed ID: 22246374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. International comparison of C-peptide measurements.
    Wiedmeyer HM; Polonsky KS; Myers GL; Little RR; Greenbaum CJ; Goldstein DE; Palmer JP
    Clin Chem; 2007 Apr; 53(4):784-7. PubMed ID: 17332147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An improved radioimmunoassay of C-peptide and its application in a multiyear study.
    Myrick JE; Gunter EW; Maggio VL; Miller DT; Hannon WH
    Clin Chem; 1989 Jan; 35(1):37-42. PubMed ID: 2910579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin Units and Conversion Factors: A Story of Truth, Boots, and Faster Half-Truths.
    Knopp JL; Holder-Pearson L; Chase JG
    J Diabetes Sci Technol; 2019 May; 13(3):597-600. PubMed ID: 30318910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implementing a Reference Measurement System for C-Peptide: Successes and Lessons Learned.
    Little RR; Wielgosz RI; Josephs R; Kinumi T; Takatsu A; Li H; Stein D; Burns C
    Clin Chem; 2017 Sep; 63(9):1447-1456. PubMed ID: 28646033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current Status of Serum Insulin and C-Peptide Measurement in Clinical Laboratories: Experience from 94 Laboratories in China.
    Zhou W; Deng Y; Zhao H; Zhang C
    Ann Lab Med; 2022 Jul; 42(4):428-437. PubMed ID: 35177563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin immunoassays: fast approaching 50 years of existence and still calling for standardization.
    Sapin R
    Clin Chem; 2007 May; 53(5):810-2. PubMed ID: 17468407
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.